k8¿­·¢(Öйú)

ÕâÊÇÃèÊöÐÅÏ¢

ÖÊÆ×¼¼Êõ

È«²¿·ÖÀà
ÁôÑÔ×Éѯ
Óë×îÐÂÏûÏ¢±£´æͬ²½
1/1
ä¯ÀÀÁ¿:
1000

TMT¶¨Á¿µ°°×ÖÊ×éѧ

TMTÊÇÓÉÃÀ¹úThermo Fisher ¹«Ë¾Ñз¢µÄÒ»ÖÖ¶àëÄÌåÍâ±ê¼Ç¼¼Êõ£¬×î¶à¿É½øÐÐ18ÀýÑù±¾µÄµ°°×ÖÊͬÅú¶¨Á¿·ÖÎö¡£TMTÊÔ¼ÁÓÉëĽáºÏ»ùÍÅ¡¢Æ½ºâ»ùÍźͱ¨¸æ»ùÍÅÈý²¿·Ö×é³É£¬¿ÉÐγÉ18 ÖÖµÈÁ¿Òìλ±êÇ©¡£
ÁãÊÛ¼Û
0.0
Ôª
Êг¡¼Û
0.0
Ôª
ä¯ÀÀÁ¿:
1000
²úÆ·±àºÅ
ËùÊô·ÖÀà
µ°°×ÖÊ×éѧ
ÊýÁ¿
-
+
¿â´æ:
0
Á¢¼´×Éѯ
1
²úÆ·ÃèÊö

       TMTÊÇÓÉÃÀ¹úThermo Fisher ¹«Ë¾Ñз¢µÄÒ»ÖÖ¶àëÄÌåÍâ±ê¼Ç¼¼Êõ£¬×î¶à¿É½øÐÐ18ÀýÑù±¾µÄµ°°×ÖÊͬÅú¶¨Á¿·ÖÎö¡£TMTÊÔ¼ÁÓÉëĽáºÏ»ùÍÅ¡¢Æ½ºâ»ùÍźͱ¨¸æ»ùÍÅÈý²¿·Ö×é³É£¬¿ÉÐγÉ18 ÖÖµÈÁ¿Òìλ±êÇ©¡£¾ßÌåʵÑéÁ÷³Ì¼°Ô­ÀíÈçÏÂͼ£ºÒÔ5ÀýÑùÆ·µÄTMT±ê¼Ç¶¨Á¿¼ì²âΪÀý¡£ÔÚʵÑé¹ý³ÌÖн«5Àý²»Í¬ÑùÆ··Ö±ðø½â³É¶àëÄƬ¶Î→·Ö±ð±ê¼Ç5ÖÖͬλËرêÇ©→½«5Àý±ê¼ÇºÃµÄ¶àëÄÑùÆ·»ìºÏ³É1Àý×ÜÑùÆ·→½øÐÐHPLC·Ö¼¶£¨Ò»°ãΪ10-15¼¶£©→·Ö¼¶ºóµÄ¶àëÄ×é·ÖÒÀ´Î½øÈëLC-MS/MS·ÖÎöϵͳ→¶þ¼¶MS½×¶ÎTMTƽºâ»ùÍÅ·¢ÉúÖÐÐÔ¶ªÊ§£¬ÔÚµÍÖÊÁ¿Çø²úÉú¶à¸ö±¨¸æÀë×Ó→¼ÆËã¸÷±¨¸æÀë×Ó·åÃæ»ý£¬»ñµÃͬһëĶβ»Í¬ÑùÆ·¼äµÄÏà¶Ô·á¶È²îÒì±ÈÖµ→¼ÓȨ¼ÆËãëĶηá¶È»ñµÃ×ܵ°°×ÖÊÏà¶Ô¶¨Á¿Öµ¡£

 

 

|   TMT±ê¼Ç¶¨Á¿¼¼ÊõÓÅÊÆ

       ´ÓTMT±ê¼Ç¶¨Á¿µ°°×ÖÊ×éѧ¼¼Êõ»ù±¾Ô­ÀíºÍʵÑéÁ÷³ÌÖÐÎÒÃÇ¿ÉÒÔ¿´³ö£¬¸Ã¼¼Êõ½«²»Í¬µÄÑù±¾·Ö±ð±ê¼Ç¶ÀÁ¢µÄTMT±êÇ©£¬ÔÙµÈÁ¿»ìºÏ³É1ÀýpoolÑù½øÈëÖÊÆ×·ÖÎö¡£ÕâÖÖÉè¼Æ±£Ö¤ÁËËùÓÐÑùÆ·¾ùÒ»ÐԵؾ­¹ýÖÊÆ×¼ì²â£¬´Ó¶ø·ÀÖ¹ÁËÑùÆ·ÒÀ´ÎÉÏÑùÔÚÖÊÆ×ÒDz¨¶¯ÆÚÒýÈëµÄÑùÆ·¼äϵͳÎó²î¡£Òò´Ë£¬Ò»°ãÑо¿ÈÏΪTMT±ê¼Ç¶¨Á¿µ°°×ÖÊ×éѧ¼¼ÊõÏà½ÏÓڷDZê¼Ç¶¨Á¿µ°°×ÖÊ×éѧ¼¼Êõ£¬ÔÚµ°°×ÖÊ×鶨Á¿±È½Ï·½Ãæ¸ü¼Ó׼ȷ¡£

      ͬʱ£¬ÓÉÓÚTMTʵÑ齫poolÑù½øÐÐHPLC·Ö¼¶´¦Àí£¬½øÐжà´ÎÖÊÆ×½øÑù£¬ÕâÑùµÄʵÑéÁ÷³Ì²»½ö½«½øÈëÖÊÆ×ÖÐÑùÆ·µÄ¸´ÔÓ¶ÈÏÔÖø½µµÍ£¬´Ó¶ø¼õÉÙÁ˱³¾°¸ÉÈÅ£¬Ìá¸ßµ°°×¼ì³öÂÊ¡£Í¬Ê±£¬²»Í¬HPLC×é·ÖÖлᱣÁôͬһµ°°×¶àëÄ£¬¾­¹ýÖÊÆ×Öظ´¼ø¶¨£¬ÔÚ¶¨ÐԺͶ¨Á¿·½Ãæ¾ù¿ÉÌá¸ßµ°°×ÖÊ×éѧµÄÊý¾Ý׼ȷ¶È£¬Ò²Ìá¸ßÁ˵°°×ÖÊ×éµÄ¼ø¶¨Éî¶È¡£Òò´Ë£¬TMT±ê¼Ç¶¨Á¿µ°°×ÖÊ×éѧ¶ÔÓÚµ°°×ÖÊ×éѧÉî¶È¼ì²âÐèÇóµÄÑо¿ÓÈΪÊÊÓá£

 

|   Ö÷ÒªÒÇÆ÷É豸

 

|   ÏîÄ¿¾­Ñé

      k8¿­·¢(Öйú)ÒѾ­Íê³ÉÉÏ°ÙÖÖÀàÐÍÑùÆ·µÄ¶¨Á¿µ°°×ÖÊ×éѧ¼ì²â£¬µ°°×ÖÊ×é±í´ï¾ßÓÐʱ¿Õ²îÒìÐÔ£¬²»Í¬Ñù±¾µÄµ°°×Æ׸÷ÓÐÌص㣬ÏÂͼɫ¿é´óС´ú±íµÄÊDz»Í¬Ñù±¾¼ø¶¨µÄµ°°×ÊýÁ¿²îÒì¡£

 

|   ÑùÆ·ÒªÇó

 

|   Ó¦Ó÷½Ïò

¡ñ   ·¢²¡»úÀíÑо¿

¡ñ   Ò©Îï°ÐµãÑо¿

¡ñ   ¼²²¡±êÖ¾Îïɸѡ

¡ñ   Ö²ÎïÆ·ÖÖ¸ÄÁ¼

¡ñ   ¹¤³Ì¾ú¸ÄÔì

¡ñ   ÌØÊ⹦Äܵ°°×ÖÊɸѡ

 

|   ¾­µä°¸Àý

TMT¼¼Êõ·¢ÏÖÖ¬·¾´úлÎÉÂҵײã»úÀí

2017Äê5ÔÂÃÀ¹úѧÕßPamir NµÈÔËÓÃTMT±ê¼Ç¼¼Êõ³É¹¦Íê³ÉÁË20ÀýСÊóÖ¬·¾×éÖ¯µ°°×ÖÊ×鶨Á¿±È½Ï¡£Ïà¹ØÑо¿¹¤×÷·¢±íÔÚµ°°×ÖÊ×éѧ´ú±íÐÔÔÓÖ¾¡¶Molecular & Cellular Proteomics¡·ÉÏ£¨PMID: 28325852£©¡£¸ÃÑо¿ÊµÑéÉè¼ÆÇÉÃͻÆÆÁËiTRAQºÍTMTµÈÌåÍâ±ê¼Çµ°°××éѧ¼¼ÊõÔÚͬλËرêÇ©ÊýÁ¿ÉϵÄÏÞÖÆ¡£

 

TMTµ°°×ÖÊ×éѧ¶¨Á¿Ñо¿ÊµÑéÉè¼Æ

Ñо¿ÈËÔ±½«8ÖÜÁäµÄ20ֻСÊó´¦Àí·Ö³ÉËÄ×飨ÿ×é5ֻСÊ󣩣º·Ö±ðµÍ֬ιÑø8ÖܺÍ18ÖÜ£¬¸ß֬ιÑø8ÖܺÍ18ÖÜ¡£·Ö±ðÈ¡¸÷СÊó¸½ØºÖ¬·¾×éÖ¯½øÐÐ3×éTMTµ°°×ÖÊ×éѧ¶¨Á¿·ÖÎö£¬¹²¼Æ20ÀýÑùÆ·£¬Í¨¹ý3Ì×TMTÊÔ¼Á“´îÇÅ”·½°¸Íê³ÉÁ˵°°×ÖÊ×éѧ¶¨Á¿·ÖÎö¡£½«3×éÖÊÆ×Êý¾ÝУ׼ºó½øÐÐ×é¼äµ°°×ÆױȽÏ£¬»ñµÃË¥ÀÏ£¨aging£©ºÍ¸ßÖ¬Òûʳ£¨HF£©µ÷¿ØµÄÖ¬·¾×éÖ¯ÌØÕ÷µ°°×Æ×£¬ÖØÐÂÈÏʶ˥ÀÏÓë¸ßÖ¬ÒûʳÓÕµ¼µÄ´úлÎÉÂÒ¼²²¡µÄÎïÖÊ»ù´¡£¬¾ßÌåʵÑéÉè¼Æ£¬¼ûͼ1¡£

 

 

ͼ1.¶àÑù±¾TMTµ°°×ÖÊ×éѧ¼¼Êõ·Ïß

 

¸ßÖ¬ÒûʳÒ×Ôì³É´úлÎÉÂÒ

¾­¹ý18¸öÔ¸ßÖ¬ÒûʳιÑø£¬Ð¡Êó³öÏÖÁË´úл״̬ϵͳÐÔÎÉÂÒ£¬Ëæʱ¼äÔö³¤Ö𽥼Ӿ硣ÔÚµÍ֬״̬Ï£¬Ë¥ÀÏÊÇÒýÆð´úлÎÉÂÒÖ÷ÒªÒòËØ£¬µ«ÎÉÂҳ̶ȽϸßÖ¬»·¾³ÒªÇᣬ¼ûͼ2¡£

 

ͼ2.¸ßÖ¬ÒûʳºÍË¥ÀÏÔì³ÉÌÇÖ¬´úлÎÉÂÒ

 

µ°°×ÖÊ×é¸Ä±ä°éËæ´úлÎÉÂÒ·¢Éú

ͨ¹ý¶Ô±È·ÖÎö×é¼ä¶¨Á¿µ°°×ÖÊ×éѧÊý¾ÝµÄ²îÒ죬Ñо¿ÈËÔ±·¢ÏÖË¥ÀÏÊÇÒýÆðµ°°×ÖÊ×é±ä»¯µÄÖØÒªÒòËØ¡£¶øÔÚ¸ßÖ¬»·¾³Ï£¬Ë¥À϶ÔÓÚµ°°×ÖÊ×éµÄµ÷±äÓ°Ï콫±»·Å´ó£¬±íÏÖΪ´úлÏà¹Ø²îÒìµ°°×ÏÔÖøÔö¶à¡£

 

ͼ3.¸ßÖ¬ÒûʳºÍË¥ÀÏÔì³Éµ°°×ÖÊ×éÏÔÖøµ÷±ä

 

      TMT¶¨Á¿µ°°×ÖÊ×éѧÊý¾Ýϵͳ±È½ÏÁËË¥ÀÏ£¨Aging£©ºÍ¸ßÖ¬Òûʳ£¨HF£©¸÷×Ôµ÷¿ØµÄÖ¬·¾×éÖ¯ÌØÕ÷µ°°×Æ×£¬·¢ÏÖ£ºµÍÖ¬ÒûʳÌõ¼þÏ£¬Ë¥ÀÏÒòËØÖ÷Ҫͨ¹ýµ÷¿ØÖ¬´úл¡¢°±»ùËá´úлÏà¹Øµ°°×Ⱥ¸Ä±äÒý·¢´úлÎÉÂÒ¡£¶øÔÚ¸ßÖ¬»·¾³Ï£¬Ë¥À϶ÔÃâÒßϵͳ¡¢²¹Ì弤»î¡¢»ùÖÊÖØËܵȵ°°×ȺÓÖ²úÉúÁËеÄÓ°Ï죬Ôì³ÉÁ˸üÑÏÖصĴúлÎÉÂÒ·¢Éú£¬¼ûÈçͼ4¡£

 

ͼ4.²îÒìµ°°×Æ×»¥×÷ÍøÂç·ÖÎö

 

С½á

ͨ¹ý±¾ÎÄ¿ÉÒÔ¿´³ö£¬µ°°×ÖÊ×éѧÑо¿¾ßÓкܴóµÄ·¢Õ¹¿Õ¼ä£¬¿ÉÒÔÌî²¹ºÜ¶àÑо¿ÖªÊ¶ÉϵĿհס£Á¼ºÃµÄʵÑéÉè¼Æ¿ÉÒÔÍ»ÆƼ¼ÊõÏÞÖÆ£¬²¢ÈÃʵÑéÊý¾Ý¾ßÓиüÇ¿µÄ˵·þÁ¦¡£

 Ïà¹ØÎÄÏ×

[1].Zhang L, Zhao Q, Cang H et al. Acute Myeloid Leukemia Cells Educate Mesenchymal Stromal Cells toward an Adipogenic Differentiation Propensity with Leukemia Promotion Capabilities. Adv Sci (Weinh). 2022 Mar 20;9(16):2105811.£¨Õã½­´óѧҽѧԺ¸½Êô¶ùͯҽԺ£©IF=15.1

[2]. Fu Y, Zhou Y, Zhang YL et al. Loss of neurodevelopmental-associated miR-592 impairs neurogenesis and causes social interaction deficits. Cell Death Dis. 2022 Apr 1;13(4):292. doi: 10.1038/s41419-022-04721-z. PMID: 35365601; PMCID: PMC8976077.£¨Í¬¼Ã´óѧҽѧԺ¸½Êôͬ¼ÃÒ½Ôº£©IF=9.0

[3]. Chen Huang, Lijun Chen, Sara R Savage, et al. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. Cancer Cell. 2021 Mar 8;39(3):361-379.e16.2.£¨À³Ë¹ÌغÍËÕÊ·ÃÜ˹ÈéÏÙÖÐÐÄ£©IF=50.3

[4]. Bo Shen, Xiao Yi, Yaoting Sun, et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell. 2020 Jul 9;182(1):59-72.e15.£¨Î÷ºþ´óѧÉúÃü¿ÆѧѧԺ½á¹¹ÉúÎïѧÖصãʵÑéÊÒ£©IF=64.5

[5]. Karsten Krug, Eric J Jaehnig, Shankha Satpathy, et al. Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy. Cell. 2020 Nov 25;183(5):1436-1456.e31.£¨ÂéÊ¡Àí¹¤Ñ§ÔººÍ¹þ·ð´óѧ²¼ÂÞµÂÑо¿Ëù£©IF=64.5

[6]. Yongchao Dou, Emily A Kawaler, Daniel Cui Zhou, et al. Proteogenomic Characterization of Endometrial Carcinoma. Cell. 2020 Feb 20;180(4):729-748.e26.£¨Å¦Ô¼´óѧҽѧԺϵͳÒÅ´«Ñ§Ñо¿Ëù£©IF=64.5

[7]. Michael A Gillette, Shankha Satpathy, Song Cao, et al. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell. 2020 Jul 9;182(1):200-225.e35.£¨ÂéÊ¡Àí¹¤Ñ§ÔººÍ¹þ·ð´óѧ²¼ÂÞµÂÑо¿Ëù£©IF=64.5

[8]. Yi-Ju Chen, Theodoros I Roumeliotis, Ya-Hsuan Chang, et al. Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression. Cell. 2020 Jul 9;182(1):226-244.e17.£¨ÖÐÑëÑо¿Ôº»¯Ñ§Ñо¿Ëù£©IF=64.5

[9]. Francesca Petralia, Nicole Tignor, Boris Reva, et al. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer. Cell. 2020 Dec 23;183(7):1962-1985.e31.£¨Î÷ÄÎɽÒÁ¿²Ò½Ñ§ÔºÒÅ´«Ñ§ºÍ»ùÒò×é¿Æѧϵ£©IF=64.5

[10].Li R, He Y, Zhu Y et al. Route to Rheumatoid Arthritis by Macrophage-Derived Microvesicle-Coated Nanoparticles. Nano Lett. 2019 Jan 9;19(1):124-134. IF=10.8£¨¸´µ©´óѧÖÇÄÜ»¯µÝÒ©½ÌÓý²¿ÖصãʵÑéÊÒ£©IF=10.8

[11]. Deanna L Plubell, Phillip A Wilmarth, Yuqi Zhao, et al. Extended multiplexing of TMT labeling reveals age and high fat diet specific proteome changes in mouse epididymal adipose tissue. Mol Cell Proteomics. 2017 May;16(5):873-890.£¨¶íÀÕ¸Ô½¡¿µÓë¿Æѧ´óѧÄÎÌØÐÄѪ¹ÜÑо¿Ëùҽѧϵ£©IF=7.0

[12]. Christopher J Tape, Stephanie Ling, Maria Dimitriadi, et al. Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation. Cell. 2016 May 5;165(4):910-20.£¨Ó¢¹ú°©Ö¢Ñо¿Ëù£©IF=64.5

δÕÒµ½ÏàÓ¦²ÎÊý×飬ÇëÓÚºǫ́ÊôÐÔÄ£°åÖÐÌí¼Ó
k8¿­·¢(Öйú)

µØÖ·£ºÉϺ£ÊÐãÉÐÐÇøÂÌÖÞ»·Â·396Ū5´±4²ã

µç»°£º400-869-2936£¬021-33968791

ÓÊÏ䣺support@wayenbiotech.com

´«Õ棺021-33938792

QQ£º2120485725

Õ½ÂÔºÏ×÷

Õ½ÂÔºÏ×÷

·¢²¼Ê±¼ä£º2021-08-11 17:21:10

|    Full Moon    |    RayBiotech    |    CDI    |    IZON    |    Bio-Rad    |    R&D Systems    |    IsoPlexis    |    ÄÏÄ£ÉúÎï    |    Å·Ò×ÉúÎï    |    ÆäÃ÷ÐÅÏ¢    |    ÃÀ¼ªÉúÎï    |    ÂóÌØ»æÆ×    | 

 

Ìرð˵Ã÷£º±¾ÍøËùÓÐÍøÒ³¾ùΪk8¿­·¢(Öйú)Ô­´´ÐÅÏ¢£¬×ªÔرØÐëÕ÷Çók8¿­·¢(Öйú)ͬÒ⣬²¢Í¬Ê±×¢Ã÷±¾ÍøÃû³Æ¼°ÍøÖ·¡£

רÀû´úÂë

·¢²¼Ê±¼ä£º2023-06-09 17:38:30
Copyright @ 2021 ÉϺ£k8¿­·¢(Öйú)Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾ °æȨËùÓÐ
Record »¦ICP±¸2022031428ºÅ-1
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ÉϺ£
ËÑË÷
ËÑË÷
¹Ø±Õ
¿Í»§ÁôÑÔ
ÑéÖ¤Âë